Plain-English translation of NCT06472375 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
When someone faints, doctors need to figure out how serious it is. Right now, many patients stay in the hospital overnight with continuous heart monitoring (called telemetry) to be safe. This trial is testing whether some patients with fainting can go home immediately instead, while wearing a portable heart monitor at home. The goal is to help doctors decide who really needs to stay overnight and who can safely leave.
Too many people are being admitted to the hospital overnight for fainting when they might not need to be. This trial will help doctors identify which patients can be safely discharged early, reducing unnecessary hospital stays and improving how fainting is managed.
You likely qualify if…
You likely don't qualify if…
If you qualify and are randomly assigned to the new approach, you will be discharged from the emergency room the same day with a portable heart monitor to wear at home. If you are assigned to the standard approach, you will stay in the hospital overnight with continuous heart monitoring before discharge. Both groups will have follow-up contact to check on your progress and safety. The study is comparing these two approaches to see which one works better for low- and intermediate-risk fainting patients.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Netherlands
Sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Enrollment target
~640 participants
Started
November 2023
Primary completion
August 2026
Age range
18 Years and older
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Frederik de Lange, MD PhD
PI
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.